Cannara Releases 14 New SKU’s Across Ontario and Quebec

MONTREAL, QUÉBEC – September 30, 2022Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a Quebec-based, vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices, announced today that it will be releasing 14 new SKU’s of its premium-grade cannabis in Ontario and Quebec under the Company’s flagship brands, Tribal, Nugz, and Orchid CBD brands.

BrandProduct NameCategoryMarket
TribalCuban Linx5 x 0.6 gram prerollsOntario
TribalCuban Linx1 gram live resin full spectrum extractOntario
TribalGalactic Rntz3.5 gram dried flowerQuebec, Ontario
TribalGalactic Rntz5 x 0.6 gram prerollsQuebec, Ontario
TribalTriple Burger3.5 gram dried flowerQuebec
TribalTriple Burger5 x 0.6 gram prerollsQuebec
TribalUni Pro ARKVape BatteryOntario
NugzSlapz3.5 gram dried flowerOntario
NugzSmalls14 gram dried flowerOntario
NugzStrain Hunter15 gram dried flowerQuebec
Orchid CBDTHC I CBD 30:15OilsQuebec
Orchid CBDTHC I CBD 15:30OilsQuebec
Orchid CBDCBD 750OilsQuebec
Orchid CBDCBD 2500OilsQuebec

“On behalf of the management team, we are excited to bring these 14 new products to our loyal customers as we continue to execute on our mission to provide high-demand premium cannabis products at affordable prices” stated Zohar Krivorot, President & CEO of Cannara Inc. “Our growth across Ontario and Quebec is a testament to the hard work of our staff and our purpose-built facilities designed to grow and process premium cannabis at scale. The demand for our products continues to increase and we look forward to bringing even more options to market as we ramp up our operations” concluded Mr. Krivorot. 

Nicholas Sosiak, CFO of Cannara commented that “our house of brands continue to satisfy our consumers with consistent premium offerings at a value proposition rarely seen in today’s market. We continue to build up on our foundation of genetics and commitment to quality with today’s announcement.” concluded Mr. Sosiak. 

Also announced today, is that the Board of Directors has approved the grant of incentive stock options for certain Directors, Officers, and Employees of the Corporation, pursuant to the Corporation’s Employee Stock Option Plan for the purchase of 7,500,000 shares at an exercise price of $0.10, and an aggregate total of 14,125,000 stock options at an exercise price of $0.18 subject to the vesting provisions of the options, at any time up to and including September 29, 2027.


CONTACT

Nicholas Sosiak, CPA, CA
Chief Financial Officer
nick@cannara.ca

Zohar Krivorot
Founder & Chief Executive Officer
zohar@cannara.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


ABOUT CANNARA

Cannara Biotech Inc. (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,600,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.